Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 256 entries
Sorted by: Best Match Show Resources per page
First Report of a Single Exon Deletion in TCOF1 Causing Treacher Collins Syndrome.

Molecular syndromology

Beygo J, Buiting K, Seland S, Lüdecke HJ, Hehr U, Lich C, Prager B, Lohmann DR, Wieczorek D.
PMID: 22712005
Mol Syndromol. 2012 Jan;2(2):53-59. doi: 10.1159/000335545. Epub 2012 Jan 26.

Treacher Collins syndrome (TCS) is a rare craniofacial disorder characterized by facial anomalies and ear defects. TCS is caused by mutations in the TCOF1 gene and follows autosomal dominant inheritance. Recently, mutations in the POLR1D and POLR1C genes have...

Cite
Beygo J, Buiting K, Seland S, et al. First Report of a Single Exon Deletion in TCOF1 Causing Treacher Collins Syndrome. Mol Syndromol. 2012;2(2):53-59doi: 10.1159/000335545.
Beygo, J., Buiting, K., Seland, S., Lüdecke, H. J., Hehr, U., Lich, C., Prager, B., Lohmann, D. R., & Wieczorek, D. (2012). First Report of a Single Exon Deletion in TCOF1 Causing Treacher Collins Syndrome. Molecular syndromology, 2(2), 53-59. https://doi.org/10.1159/000335545
Beygo, J, et al. "First Report of a Single Exon Deletion in TCOF1 Causing Treacher Collins Syndrome." Molecular syndromology vol. 2,2 (2012): 53-59. doi: https://doi.org/10.1159/000335545
Beygo J, Buiting K, Seland S, Lüdecke HJ, Hehr U, Lich C, Prager B, Lohmann DR, Wieczorek D. First Report of a Single Exon Deletion in TCOF1 Causing Treacher Collins Syndrome. Mol Syndromol. 2012 Jan;2(2):53-59. doi: 10.1159/000335545. Epub 2012 Jan 26. PMID: 22712005; PMCID: PMC3326662.
Copy Download .nbib Format: NLM
Iron in Restless Legs Syndrome.

Movement disorders clinical practice

Schulte EC, Kaffe M, Schormair B, Winkelmann J.
PMID: 30363981
Mov Disord Clin Pract. 2014 Jun 12;1(3):161-172. doi: 10.1002/mdc3.12047. eCollection 2014 Sep.

A link between restless legs syndrome (RLS) and iron has been recognized for several decades. Yet, the precise role that iron or other components of iron metabolism play in bringing about RLS is still a matter of debate. During...

Cite
Schulte EC, Kaffe M, Schormair B, et al. Iron in Restless Legs Syndrome. Mov Disord Clin Pract. 2014;1(3):161-172doi: 10.1002/mdc3.12047.
Schulte, E. C., Kaffe, M., Schormair, B., & Winkelmann, J. (2014). Iron in Restless Legs Syndrome. Movement disorders clinical practice, 1(3), 161-172. https://doi.org/10.1002/mdc3.12047
Schulte, Eva C, et al. "Iron in Restless Legs Syndrome." Movement disorders clinical practice vol. 1,3 (2014): 161-172. doi: https://doi.org/10.1002/mdc3.12047
Schulte EC, Kaffe M, Schormair B, Winkelmann J. Iron in Restless Legs Syndrome. Mov Disord Clin Pract. 2014 Jun 12;1(3):161-172. doi: 10.1002/mdc3.12047. eCollection 2014 Sep. PMID: 30363981; PMCID: PMC6183309.
Copy Download .nbib Format: NLM
Parental origin of deletions and duplications - about the necessity to check for cryptic inversions.

Molecular cytogenetics

Liehr T, Schreyer I, Kuechler A, Manolakos E, Singer S, Dufke A, Wilhelm K, Jančušková T, Čmejla R, Othman MAK, Al-Rikabi AH, Mrasek K, Ziegler M, Kankel S, Kreskowski K, Weise A.
PMID: 29541160
Mol Cytogenet. 2018 Mar 09;11:20. doi: 10.1186/s13039-018-0369-1. eCollection 2018.

BACKGROUND: Copy number variants (CNVs) are the genetic bases for microdeletion/ microduplication syndromes (MMSs). Couples with an affected child and desire to have further children are routinely tested for a potential parental origin of a specific CNV either by...

Cite
Liehr T, Schreyer I, Kuechler A, et al. Parental origin of deletions and duplications - about the necessity to check for cryptic inversions. Mol Cytogenet. 2018;11:20doi: 10.1186/s13039-018-0369-1.
Liehr, T., Schreyer, I., Kuechler, A., Manolakos, E., Singer, S., Dufke, A., Wilhelm, K., Jančušková, T., Čmejla, R., Othman, M. A. K., Al-Rikabi, A. H., Mrasek, K., Ziegler, M., Kankel, S., Kreskowski, K., & Weise, A. (2018). Parental origin of deletions and duplications - about the necessity to check for cryptic inversions. Molecular cytogenetics, 1120. https://doi.org/10.1186/s13039-018-0369-1
Liehr, Thomas, et al. "Parental origin of deletions and duplications - about the necessity to check for cryptic inversions." Molecular cytogenetics vol. 11 (2018): 20. doi: https://doi.org/10.1186/s13039-018-0369-1
Liehr T, Schreyer I, Kuechler A, Manolakos E, Singer S, Dufke A, Wilhelm K, Jančušková T, Čmejla R, Othman MAK, Al-Rikabi AH, Mrasek K, Ziegler M, Kankel S, Kreskowski K, Weise A. Parental origin of deletions and duplications - about the necessity to check for cryptic inversions. Mol Cytogenet. 2018 Mar 09;11:20. doi: 10.1186/s13039-018-0369-1. eCollection 2018. PMID: 29541160; PMCID: PMC5845138.
Copy Download .nbib Format: NLM
A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation.

Frontiers in neurology

Thomas C, Zühlsdorf A, Hörtnagel K, Mulahasanovic L, Grauer OM, Kümpers P, Wiendl H, Meuth SG.
PMID: 29887830
Front Neurol. 2018 May 25;9:383. doi: 10.3389/fneur.2018.00383. eCollection 2018.

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the presence of renal cysts and specific extrarenal abnormalities. ADPKD is caused by mutations in either

Cite
Thomas C, Zühlsdorf A, Hörtnagel K, et al. A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation. Front Neurol. 2018;9:383doi: 10.3389/fneur.2018.00383.
Thomas, C., Zühlsdorf, A., Hörtnagel, K., Mulahasanovic, L., Grauer, O. M., Kümpers, P., Wiendl, H., & Meuth, S. G. (2018). A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation. Frontiers in neurology, 9383. https://doi.org/10.3389/fneur.2018.00383
Thomas, Christian, et al. "A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation." Frontiers in neurology vol. 9 (2018): 383. doi: https://doi.org/10.3389/fneur.2018.00383
Thomas C, Zühlsdorf A, Hörtnagel K, Mulahasanovic L, Grauer OM, Kümpers P, Wiendl H, Meuth SG. A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation. Front Neurol. 2018 May 25;9:383. doi: 10.3389/fneur.2018.00383. eCollection 2018. PMID: 29887830; PMCID: PMC5980969.
Copy Download .nbib Format: NLM
High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of .

European journal of microbiology & immunology

Marlowe EM, Hardy D, Krevolin M, Gohl P, Bertram A, Arcenas R, Seiverth B, Schneider T, Liesenfeld O.
PMID: 29034107
Eur J Microbiol Immunol (Bp). 2017 Sep 11;7(3):176-186. doi: 10.1556/1886.2017.00018. eCollection 2017 Sep.

We compared the analytical and clinical performance of cobas

Cite
Marlowe EM, Hardy D, Krevolin M, et al. High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of . Eur J Microbiol Immunol (Bp). 2017;7(3):176-186doi: 10.1556/1886.2017.00018.
Marlowe, E. M., Hardy, D., Krevolin, M., Gohl, P., Bertram, A., Arcenas, R., Seiverth, B., Schneider, T., & Liesenfeld, O. (2017). High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of . European journal of microbiology & immunology, 7(3), 176-186. https://doi.org/10.1556/1886.2017.00018
Marlowe, Elizabeth M, et al. "High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of ." European journal of microbiology & immunology vol. 7,3 (2017): 176-186. doi: https://doi.org/10.1556/1886.2017.00018
Marlowe EM, Hardy D, Krevolin M, Gohl P, Bertram A, Arcenas R, Seiverth B, Schneider T, Liesenfeld O. High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of . Eur J Microbiol Immunol (Bp). 2017 Sep 11;7(3):176-186. doi: 10.1556/1886.2017.00018. eCollection 2017 Sep. PMID: 29034107; PMCID: PMC5632745.
Copy Download .nbib Format: NLM
Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?.

JIMD reports

Schene IF, Korenke CG, Huidekoper HH, van der Pol L, Dooijes D, Breur JMPJ, Biskup S, Fuchs SA, Visser G.
PMID: 30569318
JIMD Rep. 2019;45:99-104. doi: 10.1007/8904_2018_148. Epub 2018 Dec 20.

Advancements in genetic testing now allow early identification of previously unresolved neuromuscular phenotypes. To illustrate this, we here present diagnoses of glycogen storage disease IV (GSD IV) in two patients with hypotonia and delayed development of gross motor skills....

Cite
Schene IF, Korenke CG, Huidekoper HH, et al. Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?. JIMD Rep. 2018;45:99-104doi: 10.1007/8904_2018_148.
Schene, I. F., Korenke, C. G., Huidekoper, H. H., van der Pol, L., Dooijes, D., Breur, J. M. P. J., Biskup, S., Fuchs, S. A., & Visser, G. (2019). Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?. JIMD reports, 4599-104. https://doi.org/10.1007/8904_2018_148
Schene, Imre F, et al. "Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?." JIMD reports vol. 45 (2019): 99-104. doi: https://doi.org/10.1007/8904_2018_148
Schene IF, Korenke CG, Huidekoper HH, van der Pol L, Dooijes D, Breur JMPJ, Biskup S, Fuchs SA, Visser G. Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?. JIMD Rep. 2019;45:99-104. doi: 10.1007/8904_2018_148. Epub 2018 Dec 20. PMID: 30569318; PMCID: PMC6336674.
Copy Download .nbib Format: NLM
Dermatoglyphic patterns and pattern intensities of the genus Cacajao (Cebidae, platyrrhini) with observations on interspecific and subspecific differentiation.

American journal of primatology

Newell-Morris L, Wienker TF, Elias K.
PMID: 31964022
Am J Primatol. 1989;19(1):25-37. doi: 10.1002/ajp.1350190104.

Palmar and plantar dermatoglyphic pattern types, area and total pattern intensities (API and TPI), and pattern intensity (PI) profiles are presented for the South American genus Cacajao of the subfamily Pitheciinae. The data are based on prints from 41...

Cite
Newell-Morris L, Wienker TF, Elias K. Dermatoglyphic patterns and pattern intensities of the genus Cacajao (Cebidae, platyrrhini) with observations on interspecific and subspecific differentiation. Am J Primatol. 1989;19(1):25-37doi: 10.1002/ajp.1350190104.
Newell-Morris, L., Wienker, T. F., & Elias, K. (1989). Dermatoglyphic patterns and pattern intensities of the genus Cacajao (Cebidae, platyrrhini) with observations on interspecific and subspecific differentiation. American journal of primatology, 19(1), 25-37. https://doi.org/10.1002/ajp.1350190104
Newell-Morris, Laura, et al. "Dermatoglyphic patterns and pattern intensities of the genus Cacajao (Cebidae, platyrrhini) with observations on interspecific and subspecific differentiation." American journal of primatology vol. 19,1 (1989): 25-37. doi: https://doi.org/10.1002/ajp.1350190104
Newell-Morris L, Wienker TF, Elias K. Dermatoglyphic patterns and pattern intensities of the genus Cacajao (Cebidae, platyrrhini) with observations on interspecific and subspecific differentiation. Am J Primatol. 1989;19(1):25-37. doi: 10.1002/ajp.1350190104. PMID: 31964022.
Copy Download .nbib Format: NLM
Birt-Hogg-Dubé-Syndrom: ein zu selten diagnostiziertes erbliches Tumorsyndrom.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Steinlein OK, Ertl-Wagner B, Ruzicka T, Sattler EC.
PMID: 29537155
J Dtsch Dermatol Ges. 2018 Mar;16(3):278-284. doi: 10.1111/ddg.13457_g.

Das Birt-Hogg-Dubé-Syndrom (BHD-Syndrom, eigentlich Hornstein-Knickenberg- Syndrom) ist ein autosomal dominant erbliches Tumorsyndrom, welches durch Mutationen im FLCN-Gen auf Chromosom 17 verursacht wird. Patienten mit BHD-Syndrom können altersabhängig verschiedene Symptome zeigen, deren Ausprägung auch innerhalb einer Familie unterschiedlich schwer sein...

Cite
Steinlein OK, Ertl-Wagner B, Ruzicka T, et al. Birt-Hogg-Dubé-Syndrom: ein zu selten diagnostiziertes erbliches Tumorsyndrom. J Dtsch Dermatol Ges. 2018;16(3):278-284doi: 10.1111/ddg.13457_g.
Steinlein, O. K., Ertl-Wagner, B., Ruzicka, T., & Sattler, E. C. (2018). Birt-Hogg-Dubé-Syndrom: ein zu selten diagnostiziertes erbliches Tumorsyndrom. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 16(3), 278-284. https://doi.org/10.1111/ddg.13457_g
Steinlein, Ortrud K, et al. "Birt-Hogg-Dubé-Syndrom: ein zu selten diagnostiziertes erbliches Tumorsyndrom." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 16,3 (2018): 278-284. doi: https://doi.org/10.1111/ddg.13457_g
Steinlein OK, Ertl-Wagner B, Ruzicka T, Sattler EC. Birt-Hogg-Dubé-Syndrom: ein zu selten diagnostiziertes erbliches Tumorsyndrom. J Dtsch Dermatol Ges. 2018 Mar;16(3):278-284. doi: 10.1111/ddg.13457_g. PMID: 29537155.
Copy Download .nbib Format: NLM
Isolated Echogenic Cardiac Focus: Assessing Association with Trisomy 21 by Combining Results from a Prenatal Center with a Bayesian Meta-Analysis.

Ultrasound international open

Wrede E, Knippel AJ, Verde PE, Hammer R, Kozlowski P.
PMID: 32159071
Ultrasound Int Open. 2019 Nov;5(3):E98-E106. doi: 10.1055/a-1118-3974. Epub 2020 Mar 09.

No abstract available.

Cite
Wrede E, Knippel AJ, Verde PE, et al. Isolated Echogenic Cardiac Focus: Assessing Association with Trisomy 21 by Combining Results from a Prenatal Center with a Bayesian Meta-Analysis. Ultrasound Int Open. 2020;5(3):E98-E106doi: 10.1055/a-1118-3974.
Wrede, E., Knippel, A. J., Verde, P. E., Hammer, R., & Kozlowski, P. (2019). Isolated Echogenic Cardiac Focus: Assessing Association with Trisomy 21 by Combining Results from a Prenatal Center with a Bayesian Meta-Analysis. Ultrasound international open, 5(3), E98-E106. https://doi.org/10.1055/a-1118-3974
Wrede, Elisabeth, et al. "Isolated Echogenic Cardiac Focus: Assessing Association with Trisomy 21 by Combining Results from a Prenatal Center with a Bayesian Meta-Analysis." Ultrasound international open vol. 5,3 (2019): E98-E106. doi: https://doi.org/10.1055/a-1118-3974
Wrede E, Knippel AJ, Verde PE, Hammer R, Kozlowski P. Isolated Echogenic Cardiac Focus: Assessing Association with Trisomy 21 by Combining Results from a Prenatal Center with a Bayesian Meta-Analysis. Ultrasound Int Open. 2019 Nov;5(3):E98-E106. doi: 10.1055/a-1118-3974. Epub 2020 Mar 09. PMID: 32159071; PMCID: PMC7062549.
Copy Download .nbib Format: NLM
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.

Geburtshilfe und Frauenheilkunde

Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Höcht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC, Prömpeler H, Langrehr J, Leinung S, Beckmann MW, Kimmig R, Letsch A, Reinhardt M, Alt-Epping B, Kiesel L, Menke J, Gebhardt M, Steinke-Lange V, Rahner N, Lichtenegger W, Zeimet A, Hanf V, Weis J, Mueller M, Henscher U, Schmutzler RK, Meindl A, Hilpert F, Panke JE, Strnad V, Niehues C, Dauelsberg T, Niehoff P, Mayr D, Grab D, Kreißl M, Witteler R, Schorsch A, Mustea A, Petru E, Hübner J, Rose AD, Wight E, Tholen R, Bauerschmitz GJ, Fleisch M, Juhasz-Boess I, Lax S, Runnebaum I, Tempfer C, Nothacker MJ, Blödt S, Follmann M, Langer T, Raatz H, Wesselmann S, Erdogan S.
PMID: 30581199
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1089-1109. doi: 10.1055/a-0715-2964. Epub 2018 Nov 26.

No abstract available.

Cite
Emons G, Steiner E, Vordermark D, et al. Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe Frauenheilkd. 2018;78(11):1089-1109doi: 10.1055/a-0715-2964.
Emons, G., Steiner, E., Vordermark, D., Uleer, C., Bock, N., Paradies, K., Ortmann, O., Aretz, S., Mallmann, P., Kurzeder, C., Hagen, V., van Oorschot, B., Höcht, S., Feyer, P., Egerer, G., Friedrich, M., Cremer, W., Prott, F. J., Horn, L. C., Prömpeler, H., Langrehr, J., Leinung, S., Beckmann, M. W., Kimmig, R., Letsch, A., Reinhardt, M., Alt-Epping, B., Kiesel, L., Menke, J., Gebhardt, M., Steinke-Lange, V., Rahner, N., Lichtenegger, W., Zeimet, A., Hanf, V., Weis, J., Mueller, M., Henscher, U., Schmutzler, R. K., Meindl, A., Hilpert, F., Panke, J. E., Strnad, V., Niehues, C., Dauelsberg, T., Niehoff, P., Mayr, D., Grab, D., Kreißl, M., Witteler, R., Schorsch, A., Mustea, A., Petru, E., Hübner, J., Rose, A. D., Wight, E., Tholen, R., Bauerschmitz, G. J., Fleisch, M., Juhasz-Boess, I., Lax, S., Runnebaum, I., Tempfer, C., Nothacker, M. J., Blödt, S., Follmann, M., Langer, T., Raatz, H., Wesselmann, S., & Erdogan, S. (2018). Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe und Frauenheilkunde, 78(11), 1089-1109. https://doi.org/10.1055/a-0715-2964
Emons, Günter, et al. "Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities." Geburtshilfe und Frauenheilkunde vol. 78,11 (2018): 1089-1109. doi: https://doi.org/10.1055/a-0715-2964
Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Höcht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC, Prömpeler H, Langrehr J, Leinung S, Beckmann MW, Kimmig R, Letsch A, Reinhardt M, Alt-Epping B, Kiesel L, Menke J, Gebhardt M, Steinke-Lange V, Rahner N, Lichtenegger W, Zeimet A, Hanf V, Weis J, Mueller M, Henscher U, Schmutzler RK, Meindl A, Hilpert F, Panke JE, Strnad V, Niehues C, Dauelsberg T, Niehoff P, Mayr D, Grab D, Kreißl M, Witteler R, Schorsch A, Mustea A, Petru E, Hübner J, Rose AD, Wight E, Tholen R, Bauerschmitz GJ, Fleisch M, Juhasz-Boess I, Lax S, Runnebaum I, Tempfer C, Nothacker MJ, Blödt S, Follmann M, Langer T, Raatz H, Wesselmann S, Erdogan S. Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1089-1109. doi: 10.1055/a-0715-2964. Epub 2018 Nov 26. PMID: 30581199; PMCID: PMC6261739.
Copy Download .nbib Format: NLM
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.

Geburtshilfe und Frauenheilkunde

Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S.
PMID: 30581198
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088. doi: 10.1055/a-0646-4630. Epub 2018 Nov 26.

No abstract available.

Cite
Wöckel A, Festl J, Stüber T, et al. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe Frauenheilkd. 2018;78(11):1056-1088doi: 10.1055/a-0646-4630.
Wöckel, A., Festl, J., Stüber, T., Brust, K., Krockenberger, M., Heuschmann, P. U., Jírů-Hillmann, S., Albert, U. S., Budach, W., Follmann, M., Janni, W., Kopp, I., Kreienberg, R., Kühn, T., Langer, T., Nothacker, M., Scharl, A., Schreer, I., Link, H., Engel, J., Fehm, T., Weis, J., Welt, A., Steckelberg, A., Feyer, P., König, K., Hahne, A., Baumgartner, T., Kreipe, H. H., Knoefel, W. T., Denkinger, M., Brucker, S., Lüftner, D., Kubisch, C., Gerlach, C., Lebeau, A., Siedentopf, F., Petersen, C., Bartsch, H. H., Schulz-Wendtland, R., Hahn, M., Hanf, V., Müller-Schimpfle, M., Henscher, U., Roncarati, R., Katalinic, A., Heitmann, C., Honegger, C., Paradies, K., Bjelic-Radisic, V., Degenhardt, F., Wenz, F., Rick, O., Hölzel, D., Zaiss, M., Kemper, G., Budach, V., Denkert, C., Gerber, B., Tesch, H., Hirsmüller, S., Sinn, H. P., Dunst, J., Münstedt, K., Bick, U., Fallenberg, E., Tholen, R., Hung, R., Baumann, F., Beckmann, M. W., Blohmer, J., Fasching, P., Lux, M. P., Harbeck, N., Hadji, P., Hauner, H., Heywang-Köbrunner, S., Huober, J., Hübner, J., Jackisch, C., Loibl, S., Lück, H. J., von Minckwitz, G., Möbus, V., Müller, V., Nöthlings, U., Schmidt, M., Schmutzler, R., Schneeweiss, A., Schütz, F., Stickeler, E., Thomssen, C., Untch, M., Wesselmann, S., Bücker, A., Buck, A., & Stangl, S. (2018). Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe und Frauenheilkunde, 78(11), 1056-1088. https://doi.org/10.1055/a-0646-4630
Wöckel, Achim, et al. "Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer." Geburtshilfe und Frauenheilkunde vol. 78,11 (2018): 1056-1088. doi: https://doi.org/10.1055/a-0646-4630
Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088. doi: 10.1055/a-0646-4630. Epub 2018 Nov 26. PMID: 30581198; PMCID: PMC6261741.
Copy Download .nbib Format: NLM
CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance.

Frontiers in immunology

Seckinger A, Hillengass J, Emde M, Beck S, Kimmich C, Dittrich T, Hundemer M, Jauch A, Hegenbart U, Raab MS, Ho AD, Schönland S, Hose D.
PMID: 30079070
Front Immunol. 2018 Jul 20;9:1676. doi: 10.3389/fimmu.2018.01676. eCollection 2018.

Monoclonal antibodies against the cell surface antigen CD38, e.g., isatuximab, daratumumab, or Mor202, have entered the therapeutic armamentarium in multiple myeloma due to single agent overall response rates of 29 vs. 36 vs. 31%, effectivity in combination regimen, e.g.,...

Cite
Seckinger A, Hillengass J, Emde M, et al. CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance. Front Immunol. 2018;9:1676doi: 10.3389/fimmu.2018.01676.
Seckinger, A., Hillengass, J., Emde, M., Beck, S., Kimmich, C., Dittrich, T., Hundemer, M., Jauch, A., Hegenbart, U., Raab, M. S., Ho, A. D., Schönland, S., & Hose, D. (2018). CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance. Frontiers in immunology, 91676. https://doi.org/10.3389/fimmu.2018.01676
Seckinger, Anja, et al. "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance." Frontiers in immunology vol. 9 (2018): 1676. doi: https://doi.org/10.3389/fimmu.2018.01676
Seckinger A, Hillengass J, Emde M, Beck S, Kimmich C, Dittrich T, Hundemer M, Jauch A, Hegenbart U, Raab MS, Ho AD, Schönland S, Hose D. CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance. Front Immunol. 2018 Jul 20;9:1676. doi: 10.3389/fimmu.2018.01676. eCollection 2018. PMID: 30079070; PMCID: PMC6062598.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 256 entries